Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.aed2424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Erwan Morgand und 27 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, Laboratory of Integrative Cancer Immunology, F-75006 Paris, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Carcinogenesis, Precancerous Conditions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Congressionally Directed Medical Research Programs, Qatar National Research Fund, Institut national de la santé et de la recherche médicale.
Abstract (Originalsprache)
Early cancer detection and prophylactic intervention remain the primary strategies for reducing colorectal carcinoma incidence and mortality. Although the immune microenvironment and tumor-associated antigens have been shown to play a pivotal role in carcinogenesis, the factors shaping immune dynamics during the premalignant phase remain poorly understood. In this study, we performed a comprehensive multimodal characterization of the immune microenvironment in 258 longitudinal premalignant colorectal lesions. Using a discovery cohort of 135 lesions from 26 patients stratified by low versus high polyp development rate, we identified distinct immune states associated with polyp burden. These findings were validated in an independent cohort of 123 lesions from 43 patients. Lesions from patients with low polyp development rates exhibited signatures of robust immune surveillance characterized by enhanced adaptive immune infiltration, including defined T cell subsets, and a higher prevalence of mature tertiary lymphoid structures compared with lesions from patients with high polyp frequency. These immune features were accompanied by increased expression of noncoding RNAs. These transcripts were predicted to encode noncanonical antigens with high MHC-I (major histocompatibility complex class I) binding affinity, potentially increasing lesion immunogenicity. We propose that early carcinogenesis is shaped by the immune microenvironment in association with noncoding RNAs, revealing potential early biomarkers in individuals at high risk of developing colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- INSERM, Laboratory of Integrative Cancer Immunology, F-75006 Paris, France.
- Equipe Labellisée Ligue Contre le Cancer, F-75006 Paris, France.
- Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, F-75006 Paris, France.
- Institut Roi Albert II, Department of Medical Oncology Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Université Catholique de Louvain, 1200 Brussels, Belgium.
- Department of Pathology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole GAEN) Université Catholique de Louvain, 1200 Brussels, Belgium.
- Université Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, 75015 Paris, France.
ORCID-Profile: Erwan Morgand, Marc Van den Eynde, Ha Nguyen, Anne-Françoise Batto, Bernhard Mlecnik, Pamela Baldin, Amine Majdi, Tessa Fredriksen, Lucie Lafontaine, Gabriela Bindea, Mohammad Shararah, Angela Vasaturo, Pauline Maby, Rodrigo Nalio Ramos, Paula Gragera, Amos Kirilovsky, Carine El Sissy, Franck Pagès, Fazulur Rehaman Vempalli, Wouter Hendrickx, Tariq Masoodi, Michele Ceccarelli, Davide Bedognetti, Jérôme Galon
Förderung
- Congressionally Directed Medical Research Programs
- Qatar National Research Fund
- Institut national de la santé et de la recherche médicale
- ANR
- INSERM-Transfert
- La Ligue Contre Le Cancer
- SIRIC
- Transcan ERAnet
Zitieren
APA
Morgand, E., Van den Eynde, M., Nguyen, H., Batto, A. F., Mlecnik, B., Baldin, P., Majdi, A., Fredriksen, T., Lafontaine, L., Bindea, G., Mezine, F., Shararah, M., Vasaturo, A., Hijazi, A., Buttard, B., Maby, P., Ramos, R. N., Gragera, P., Kirilovsky, A., …, & Galon, J. (2026). Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aed2424
Vancouver
Morgand E, Van den Eynde M, Nguyen H, Batto AF, Mlecnik B, Baldin P, et al. Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aed2424
BibTeX
@article{Morgand2026,
author = {Morgand, Erwan and Van den Eynde, Marc and Nguyen, Ha and Batto, Anne-Françoise and Mlecnik, Bernhard and Baldin, Pamela and Majdi, Amine and Fredriksen, Tessa and Lafontaine, Lucie and Bindea, Gabriela and Mezine, Fariza and Shararah, Mohammad and Vasaturo, Angela and Hijazi, Assia and Buttard, Bénédicte and Maby, Pauline and Ramos, Rodrigo Nalio and Gragera, Paula and Kirilovsky, Amos and El Sissy, Carine and Marliot, Florence and Pagès, Franck and Vempalli, Fazulur Rehaman and Hendrickx, Wouter and Masoodi, Tariq and Ceccarelli, Michele and Bedognetti, Davide and Galon, Jérôme},
title = {Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.aed2424}
}
EUVIMED